FDA is temporarily suspending certain Clozapine REMS program requirements to ensure continuity of care for patients taking clozapine

[FDA]

Full launch for the Clozapine Risk Evaluation and Mitigation Strategy (REMS) program will not be implemented in 2016


Baca selengkapnya di : http://www.fda.gov...